Armata Pharmaceuticals Inc — Quarterly Financial Statistics (NYSE:ARMP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -7.93 M-7.58 M-7.21 M-4.3 M-6.67 M -25.76 M Cash from investing activities 77 K-99 K-149 K-242 K-52 K -542 K Cash from financing activities 09.99 M014.97 M658 K 25.61 M Free cash flow -7.85 M-7.68 M-7.36 M-4.54 M-6.73 M -26.3 M

News

H.C. Wainwright lowers Armata Pharmaceuticals stock price target to $15

Armata Pharmaceuticals stock gains on FDA designation

FDA grants QIDP status to Armata’s staph infection treatment

Innoviva stock gains BTIG coverage with buy rating on royalty windfall

Armata to advance bacteriophage therapy to phase 3 for S. aureus

Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating

Armata Pharma earnings missed by $0.24, revenue fell short of estimates

Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates

Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates

Armata Pharmaceuticals commissions phage manufacturing facility

Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates

Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates